APA (7th ed.) Citation

Laskin, J., Liu, S. V., Tolba, K. A., Heining, C., Schlenk, R. F., Cheema, P., . . . Duruisseaux, M. (2020). NRG1 fusion-driven tumors: Biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Annals of oncology, 31(12), . https://doi.org/10.1016/j.annonc.2020.08.2335

Chicago Style (17th ed.) Citation

Laskin, Janessa, et al. "NRG1 Fusion-driven Tumors: Biology, Detection, and the Therapeutic Role of Afatinib and Other ErbB-targeting Agents." Annals of Oncology 31, no. 12 (2020). https://doi.org/10.1016/j.annonc.2020.08.2335.

MLA (9th ed.) Citation

Laskin, Janessa, et al. "NRG1 Fusion-driven Tumors: Biology, Detection, and the Therapeutic Role of Afatinib and Other ErbB-targeting Agents." Annals of Oncology, vol. 31, no. 12, 2020, https://doi.org/10.1016/j.annonc.2020.08.2335.